Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers

Nature·May 18

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is being conducted on the feasibility of using whole genome and transcriptome profiling in pediatric and young adult cancers. Studies have shown potential benefits of this approach, including improved diagnostic yield and risk assessment in certain types of cancer. The clinical utility and implementation of whole genome and transcriptome sequencing in routine healthcare are also being explored.

Full coverage

Real-world clinical utility of tumor whole-genome sequencing in solid cancers

Nature·Mar 20

Whole Genome and Transcriptome Sequencing Improves Diagnostic Yield in Unresolved Hematologic Neoplasms: Evidence from the SIRIUS Study

Vera Health·Dec 19

Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing

Nature·Apr 7

Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment

Nature·Oct 7

Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology

Nature·Nov 27

Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort

Nature·Jan 12

A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practice

Nature·Nov 4

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology

Nature·Jan 10

View original report at Nature ↗

Fetching the latest headlines…